Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3252-3264
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3252
Table 2 Patient-level characteristics of hospitalizations with specific rheumatic diseases
Characteristics
Lupus (n = 397935)
Ankylosing Spondylitis (n = 39250)
Sjogren syndrome (n = 114885)
Dermato-polymyositis (n = 30400)
Scleroderma (n = 69865)
Rheumatoid arthritis (n = 1249979)
Gout (n = 1953389)
Reactive arthritis (n = 5690)
Psoriaticarthritis (n = 87110)
Pseudogout (n = 43375)
Polymyalgia rheumatica (n = 172655)
Enteropathic arthritis (n = 935)
Vasculitis (n = 47125)
Age, yr, mean ± SD52.1 ± 16.960.2 ± 16.264 ± 15.5 60.6 ± 16.562.6 ± 14.467.2 ± 14.270.5 ± 12.954.8 ± 17.960.8 ± 13.975.4 ± 12.179.1 ± 9.445.6 ± 17.460.9 ± 16.3
Gender
Male11.5%65.1%8.4%31.5%15.5%26%67.5%63.3%42.8%48.5%31.7%37.9%47.5%
Female88.5%34.9%91.5%68.5%84.5%74%32.5%36.7%57.2%51.4%68.3%62%52.5%
Elixhauser Comorbidities
Afib.9.9%14.7%14.7%16.5%17.3%18.9%30.2%12%14.7%27.1%33.2%3.2%18.2%
Coronary Arterial Disease17.9%21.5%18.9%21.7%22.5%25.8%38.7%16.1%21.6%28.6%35.3%7.5%22.7%
Congestive heart failure12.8%10.1%11%14.2%17.7%14.1%21.1%8.6%8.8%15.5%18.5%5.3%15.7%
Obstructive sleep apnea7.4%11.1%10.2%9.4%7.8%9.7%16.4%8.6%14.7%7.8%11.2%6.4%9.4%
Valvular disease4%3.5%4.7%3.5%5.5%4.4%5%2.7%3.2%7.1%7.5%0.5%4.3%
Chronic pulmonary disease22.3%19.3%24.2%18.7%23.1%27.8%22.8%17.9%21.9%18.5%23.2%17.6%28.2%
Hypertension53.4%52.7%51.6%53.9%50.8%61.1%69.4%44.8%58.2%68.9%67.6%26.7%58.4%
Diabetes w/o chronic complications8.9%11.7%8.5%14,5%6.8%12.9%15.9%7.9%13.5%12.6%12.6%9.1%8.6%
Diabetes w/ chronic complications9.7%10.6%8%13.4%7%12.1%23%10.7%14.4%14.2%14.6%4.8%14.2%
Pulmonary Hypertension6.6%3.5%7.5%8.7%29.5%5.5%8.3%2.1%3.8%4.9%6.9%1.1%5.8%
Hypothyroidism15.3%10.1%23.9%14.7%20.5%17.7%14.2%8.2%15.6%16.5%22.5%6.4%12.6%
Renal failure23.5%11.5%13.3%10.9%17.4%14.7%37.1%11.1%11.6%20.6%23.6%4.8%39.1%
Obesity15.5%15.3%13.5%14.9%7.5%15.3%21.8%11.7%23.4%11.1%11.6%14.4%12.7%
Alcohol abuse1.7%3.5%1%1.4%1.4%2.1%4.2%4.3%4.4%2.9%1.1%0.5%2.4%
Drug abuse4.9%4.9%2.5%2.5%2.6%3.2%1.7%7.5%3.6%1.8%1.1%5.3%3.5%
Depression15.6%14.6%17.2%12.5%13.2%15.6%10.4%10.5%17.6%10.7%13.9%14.9%11.1%
Outcomes
In-hospital mortality 1.9%2.4%2%3.5%4.8%2.3%2.4%1.3%1.4%1.1%2.6%2.1%4%
Length of stay, d, mean ± SD5.5 ± 6.95.5 ± 7.45.1 ± 6.36.9 ± 8.76.2 ± 7.65 ± 5.45.4 ± 5.95.8 ± 6.34.9 ± 5.66 ± 6.7 4.9 ± 4.65.8 ± 8.67.1 ± 8.8
Total hospitalization cost, $, mean ± SD14389 ± 2114817661 ± 2262414213 ± 1936719190 ± 3903017052 ± 2949713744 ± 1624514566 ± 1834414343 ± 1769314726 ± 1809714742 ± 1892413368 ± 1494316008 ± 2598919874 ± 29132